HCPCS code J2427 — Inj, invega hafyera/trinza.
Status: Active.
Effective Jul 1, 2023.
Source: CMS HCPCS Level II.
J2427
ActiveInj, invega hafyera/trinza
Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
Category:
Drugs
Section:
J-codes: Drugs Administered Other Than Oral Method
Effective:
Jul 1, 2023
Code type:
alphanumeric
OPPS Status:
K
— Non-pass-through drugs and biologicals
OPPS APC:
9145
MUE — Medically Unlikely Edits
Maximum units of J2427 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| Outpatient Hospital | 1560 |
| Practitioner Services | 1560 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 50458-0606-01 | Invega Trinza |
| 50458-0607-01 | Invega Trinza |
| 50458-0608-01 | Invega Trinza |
| 50458-0609-01 | Invega Trinza |
| 50458-0611-01 | Invega Hafyera |
| 50458-0612-01 | Invega Hafyera |
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.
-
New Code 2023-Q3Inj, invega hafyera/trinza